BIBAG

fresenius medical care canada inc🇨🇦 Health Canada

Approval Id: 7a3b9fa01b3ca122
Drug Approval Canada Name: BIBAG
Product Name: BIBAG
Status: Marketed
Status Date: 2022-04-26
Original Market Date: 2020-01-30
Din: 02487756
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Haemodialysis
Schedule: Ethical
Ahfs: 40:34.00*
Atc Original: B05ZA HEMODIALYTICS, CONCENTRATES
Atc Name: b 05 za
Aig Number: 0104153026
Company Name: fresenius medical care canada inc
Company Address: 45 Staples Ave, Suite 110, Richmond Hill, Ontario, Canada, L4B 4W6

SODIUM BICARBONATE

900 G / BAG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

7a3b9fa01b3ca122

Type

Standard